修订EORTC肺癌患者生活质量问卷的国际研究
该国际多中心研究遵循EORTC模块开发指南,在108例肺癌患者参与下生成条目,并在9国12中心200例组织学确诊肺癌患者中评估48项暂定模块。29个问题符合预设统计标准,形成保留原13项中12项并新增17项的EORTC QLQ-LC29。
要点
- 研究遵循EORTC模块开发指南I至III期,生成48项暂定肺癌模块。
- III期研究纳入9国12中心200例组织学确诊肺癌患者,平均年龄64岁(39-91)。
- 48个问题中29个符合预设统计标准,形成EORTC QLQ-LC29。
核心结论
- 形成的29项模块命名为EORTC QLQ-LC29,保留原13项中的12项,新增17项主要评估传统和新型治疗的副作用。
研究设计与样本
- 研究遵循EORTC模块开发指南的I至III期,I期通过多种来源(包括108例肺癌患者参与)生成相关生活质量问题,II期将问题转化为问卷条目。
- III期为国际多中心研究,来自9个国家(塞浦路斯、德国、意大利、以色列、西班牙、挪威、波兰、台湾和英国)12个中心的200例组织学确诊肺癌患者完成EORTC QLQ-C30和48项暂定肺癌模块。
主要发现
- III期研究纳入200例患者,平均年龄64岁(范围39-91),59%为男性,82%为非小细胞肺癌,56%接受姑息性治疗。
- 48个问题中29个符合预设统计标准,被纳入最终模块。
- 最终模块保留原13项中的12项,新增17项主要评估传统和新型治疗的副作用。
关键数值与推荐
- 患者对每个条目的相关性、可理解性和可接受性进行评分,并与预设统计标准比较。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-LC13 was the first module to be used in conjunction with the core questionnaire, the QLQ-C30. Since the publication of the LC13 in 1994, major advances have occurred in the treatment of lung cancer. Given this, an update of the EORTC QLQ-LC13 was undertaken. METHODS: The study followed phases I to III of the EORTC Module Development Guidelines. Phase I generated relevant quality-of-life issues using a mix of sources including the involvement of 108 lung cancer patients. Phase II transformed issues into questionnaire items. In an international multicenter study (phase III), patients completed both the EORTC QLQ-C30 and the 48-item provisional lung cancer module generated in phases I and II. Patients rated each of the items regarding relevance, comprehensibility, and acceptance. Patient ratings were assessed against a set of prespecified statistical criteria. Descriptive statistics and basic psychometric analyses were carried out. RESULTS: The phase III study enrolled 200 patients with histologically confirmed lung cancer from 12 centers in nine countries (Cyprus, Germany, Italy, Israel, Spain, Norway, Poland, Taiwan, and the UK). Mean age was 64 years (39 - 91), 59% of the patients were male, 82% had non-small-cell lung cancer, and 56% were treated with palliative intent. Twenty-nine of the 48 questions met the criteria for inclusion. CONCLUSIONS: The resulting module with 29 questions, thus currently named EORTC QLQ-LC29, retained 12 of the 13 original items, supplemented with 17 items that primarily assess treatment side-effects of traditional and newer therapies.
引用
- Koller M, Hjermstad MJ, Tomaszewski KA, et al. An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients. Ann Oncol. 2017. PMID: 28945875. doi:10.1093/annonc/mdx453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。